Related Experiment Video

Updated: May 15, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.5K

[Risk of cardiovascular disease associated with ADHD treatment]

Anders Holt1, Morten Lamberts1,2, Hanne Elberling3

  • 1Hjertemedicinsk Afdeling, Københavns Universitetshospital - Herlev og Gentofte Hospital.

Ugeskrift for Laeger
|May 14, 2025
PubMed

Insights

The medical treatment for attention-deficit/hyperactivity disorder (ADHD) may increase cardiovascular risks, particularly with higher doses or prolonged use. While not definitively proven, regular clinical monitoring, including blood pressure and heart rate, is recommended for adult patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • The sympathetic nervous system's role in ADHD treatment is debated.
  • Observational studies suggest a potential link between ADHD medications and cardiovascular disease.
  • Existing research indicates a possible dose- and duration-dependent risk.

Purpose of the Study:

  • To review the current evidence on cardiovascular side effects of ADHD treatment.
  • To discuss the implications of sympathetic nervous system activation by ADHD medications.
  • To provide recommendations for monitoring cardiovascular health in treated adults.

Main Methods:

  • Literature review of observational studies and clinical trial data.
  • Analysis of sympathetic nervous system effects of common ADHD pharmacotherapies.
  • Synthesis of current guidelines and expert opinions.

Main Results:

  • A causal link between ADHD treatment and cardiovascular disease remains unproven.
  • Observational data suggest an elevated risk, especially with higher doses and longer treatment durations.
  • The agonistic effect on the sympathetic nervous system is a key area of concern.

Conclusions:

  • Clinical monitoring of blood pressure and heart rate is advised for all adult ADHD patients on medication.
  • Electrocardiograms and biochemical tests (lipids, HbA1c) may be beneficial for comprehensive cardiovascular risk assessment.
  • Further research is needed to establish causality and refine monitoring strategies.

More Related Videos

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.1K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.6K

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
27
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
19
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
496
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
624